CMS has posted updated average sales price (ASP) files with payment rates for Part B covered drugs for the first quarter of 2014, based on third quarter 2013 data. According to CMS, average drug prices in the market remain relatively stable, with average prices for the top Part B drugs decreasing by 1.4%.